Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORC and HA for Adhesion Prevention in Thyroid Surgery
NCT05851560Phase 1Completed
- Sponsor
- National Taiwan University Hospital
- Start
- May 2023
- Primary completion
- Sep 2023
- Modality
- Polymer-based Nanoparticles, Device-based Delivery, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of oxidized and regenerated cellulose and hyaluronic acid (3 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Dysphagia Handicap Index. Started May 2023; status: completed.
02
Drugs
oxidized and regenerated cellulosehyaluronic acid
Beyond the preview
Go deeper on NCT05851560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05851560.